Company | Name | Exchange | Sector | Industry | 6 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Park Ha Biological Tech | NASDAQ | Consumer Cyclicals | Specialty Retailers | 386.5% | USD 522.21M | 347.4x | -24.89 | USD 19.80 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jiayin | NASDAQ | Technology | Software & IT Services | 174.7% | USD 969.72M | 1.83 | USD 18.17 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
China Yuchai | NYSE | Consumer Cyclicals | Automobiles & Auto Parts | 124% | USD 782.26M | 14.7x | 0.99 | USD 20.85 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -14.6% Downside | Upgrade to Pro+ | |
Vasta Platform | NASDAQ | Academic & Educational Services | Miscellaneous Educational Service Providers | 108.3% | USD 344.10M | 4x | 0 | USD 4.29 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -28.4% Downside | Upgrade to Pro+ | |
Alpha Technology | NASDAQ | Technology | Software & IT Services | 65.5% | USD 425.56M | -486.4x | -17.21 | USD 24.75 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
B Communications | OTC Markets | Technology | Telecommunications Services | 57.3% | USD 538.85M | 27.5x | -0.45 | USD 5.41 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Yirendai Ltd | NYSE | Financial | Banking Services | 36.8% | USD 547.82M | 3.1x | -0.08 | USD 6.34 | -6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Transcontinental | NYSE | Real Estate | Real Estate Operations | 35.5% | USD 329.76M | 36x | 0.7 | USD 38.17 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Soho House | NYSE | Technology | Software & IT Services | 34.7% | USD 1.30B | -10.7x | -0.43 | USD 6.68 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.7% Upside | Upgrade to Pro+ | |
Sify | NASDAQ | Technology | Telecommunications Services | 32.3% | USD 308.21M | -29.1x | 0.1 | USD 4.26 | -5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zhengye Biotechnology Holding | NASDAQ | Healthcare | Pharmaceuticals | 30.5% | USD 300.46M | -1.98 | USD 6.34 | -13% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Liminatus Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 27.7% | USD 375.13M | -177.7x | 0.25 | USD 14.42 | -29% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rhoen Klinikum ADR | OTC Markets | Healthcare | Healthcare Providers & Services | 26.4% | USD 997.61M | 21.7x | -2.73 | USD 7.65 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |